Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Operations: 2009-2025

Historic Cash from Operations for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $57.5 million.

  • Prestige Consumer Healthcare's Cash from Operations fell 17.64% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.4 million, marking a year-over-year increase of 0.18%. This contributed to the annual value of $251.5 million for FY2025, which is 1.04% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Cash from Operations stood at $57.5 million, which was down 27.24% from $79.0 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's Cash from Operations' 5-year high stood at $79.0 million during Q2 2025, with a 5-year trough of $48.1 million in Q2 2023.
  • For the 3-year period, Prestige Consumer Healthcare's Cash from Operations averaged around $63.3 million, with its median value being $62.5 million (2023).
  • Over the last 5 years, Prestige Consumer Healthcare's Cash from Operations had its largest YoY gain of 44.25% in 2025, and its largest YoY loss of 17.64% in 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash from Operations (MRQ) stood at $66.3 million in 2021, then decreased by 17.13% to $54.9 million in 2022, then soared by 30.09% to $71.5 million in 2023, then fell by 8.93% to $65.1 million in 2024, then fell by 11.68% to $57.5 million in 2025.
  • Its Cash from Operations was $57.5 million in Q3 2025, compared to $79.0 million in Q2 2025 and $61.8 million in Q1 2025.